Skin test skip for Kids' antibiotic allergies shows promise
NCT ID NCT03553251
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether children under 16 with a history of mild beta-lactam (like penicillin) allergies could safely take the drug again without first having skin tests. Researchers used a questionnaire to identify low-risk kids and then gave them an oral dose. The goal was to see if this approach kept severe allergic reactions below 2%. The study involved 195 children and aimed to simplify allergy care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
beta-lactam antibiotics (e.g., penicillin)
What this could lead to
If successful, this could lead to simpler, faster allergy testing for children, avoiding unnecessary skin tests and allowing safe use of common antibiotics.
What could go wrong
This is a small, completed study with 195 children, so results may not apply to all kids. There is still a small risk of allergic reaction, and the approach only works for those already deemed low-risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERSENSITIVITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nantes University Hospital
Nantes, Loire-Atlantique, 44093, France